Endothelial dysfunction in pulmonary hypertension

Editorial

J Loscalzo. N Engl J Med. 1992.

. 1992 Jul 9;327(2):117-9.

doi: 10.1056/NEJM199207093270209.

No abstract available

Comment in

Thromboxane and prostacyclin metabolites in pulmonary hypertension.
Cacoub P, Dorent R, Carayon A. Cacoub P, et al. N Engl J Med. 1992 Nov 12;327(20):1456-7; author reply 1458. doi: 10.1056/NEJM199211123272012. N Engl J Med. 1992. PMID: 1406867 No abstract available.

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. Christman BW, et al. N Engl J Med. 1992 Jul 9;327(2):70-5. doi: 10.1056/NEJM199207093270202. N Engl J Med. 1992. PMID: 1603138
The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.
Rich S, Kaufmann E, Levy PS. Rich S, et al. N Engl J Med. 1992 Jul 9;327(2):76-81. doi: 10.1056/NEJM199207093270203. N Engl J Med. 1992. PMID: 1603139 Clinical Trial.